Jan 18, 2023 / 04:30PM GMT
Mayank Mamtani - B. Riley Securities, Inc., Research Division - MD, Senior Biotech Research Analyst & Group Head of Healthcare
Good morning. We'll get started with our next company, Agenus Bio, where we have with us Chairman and CEO, Garo Armen; and Chief Medical Officer, Dr. Steven O'Day. Thanks to the team for being part of the B. Riley oncology conference, and appreciate you guys in the audience joining us. This is Mayank Mamtani, one of the senior biotech analysts on the health care research team. At any point during the fireside chat, feel free to e-mail me questions at [email protected].
So with that, Garo, Dr. O'Day, congrats on having a very productive past 12 to 18 months with the ongoing Phase I bot/bal trial, generating quite impressive data at recent medical conferences, including the ASCO GI conference starting actually today.
Questions and Answers:
Mayank Mamtani - B. Riley Securities, Inc., Research Division - MD, Senior Biotech Research Analyst & Group Head of HealthcareBefore we dig into some of those data sets,
Trustpilot
